Acadia Pharmaceuticals



Ebitda Changement Date
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
ALKERMES USD 21.21M 142.21M 2025-03
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Corcept Therapeutics USD 25.54M 21.37M 2024-12
Cytokinetics USD -136657000 1.73M 2024-12
Eisai JPY 37.6B 13.2B 2024-12
Eli Lilly USD 4.16B 2B 2025-03
Incyte USD 222.66M 97.54M 2025-03
J&J USD 7.88B 1.76B 2025-03
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Prothena USD -64676000 1.61M 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Acadia Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.